BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 20920404)

  • 1. [Stem cell therapy for neurodegenerative disorders].
    Meyer M; Jensen P; Rasmussen JZ
    Ugeskr Laeger; 2010 Sep; 172(38):2604-7. PubMed ID: 20920404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.
    Drouin-Ouellet J
    Neurodegener Dis Manag; 2014; 4(4):297-307. PubMed ID: 25313986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation of stem cell therapy for neurological diseases.
    Schwarz SC; Schwarz J
    Transl Res; 2010 Sep; 156(3):155-60. PubMed ID: 20801412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [10 years of substitution therapy for neurodegenerative diseases using fetal neuron grafts: a positive outcome but with questions for the future].
    Peschanski M
    J Soc Biol; 2001; 195(1):51-5. PubMed ID: 11530501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult human neural stem cells for autologous cell replacement therapies for neurodegenerative disorders.
    Galvin KA; Jones DG
    NeuroRehabilitation; 2006; 21(3):255-65. PubMed ID: 17167195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restoration of brain function by cell transplantation].
    Kakishita K; Nakao N; Itakura T
    Nihon Rinsho; 2003 Mar; 61(3):457-62. PubMed ID: 12701173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell therapy for human neurodegenerative disorders-how to make it work.
    Lindvall O; Kokaia Z; Martinez-Serrano A
    Nat Med; 2004 Jul; 10 Suppl():S42-50. PubMed ID: 15272269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent stem cells as new drugs? The example of Parkinson's disease.
    Preynat-Seauve O; Burkhard PR; Villard J; Zingg W; Ginovart N; Feki A; Dubois-Dauphin M; Hurst SA; Mauron A; Jaconi M; Krause KH
    Int J Pharm; 2009 Nov; 381(2):113-21. PubMed ID: 19782880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell therapy in Parkinson's disease].
    Shingo T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):951-3. PubMed ID: 15651341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell-based cell therapy for Huntington disease: a review.
    Kim M; Lee ST; Chu K; Kim SU
    Neuropathology; 2008 Feb; 28(1):1-9. PubMed ID: 18069970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: stem cells for the treatment of cerebellar-related disorders.
    Erceg S; Moreno-Manzano V; Garita-Hernandez M; Stojkovic M; Bhattacharya SS
    Stem Cells; 2011 Apr; 29(4):564-9. PubMed ID: 21319272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
    Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
    Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells and nuclear reprogramming.
    Saric T; Hescheler J
    Minim Invasive Ther Allied Technol; 2008; 17(2):64-78. PubMed ID: 18465442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases.
    Kan I; Melamed E; Offen D
    Handb Exp Pharmacol; 2007; (180):219-42. PubMed ID: 17554511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state of stem cell research for the treatment of Parkinson's disease.
    Gerlach M; Braak H; Hartmann A; Jost WH; Odin P; Priller J; Schwarz J
    J Neurol; 2002 Oct; 249 Suppl 3():III/33-5. PubMed ID: 12522570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases.
    Lescaudron L; Boyer C; Bonnamain V; Fink KD; Lévêque X; Rossignol J; Nerrière-Daguin V; Malouet AC; Lelan F; Dey ND; Michel-Monigadon D; Lu M; Neveu I; von Hörsten S; Naveilhan P; Dunbar GL
    Methods Mol Biol; 2012; 879():147-64. PubMed ID: 22610559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-cell-based strategies for the treatment of Parkinson's disease.
    Parish CL; Arenas E
    Neurodegener Dis; 2007; 4(4):339-47. PubMed ID: 17627139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.